These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2288999)

  • 1. Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks.
    Kalus O; Kahn RS; Wetzler S; Asnis GM; van Praag HM
    Biol Psychiatry; 1990 Dec; 28(12):1053-7. PubMed ID: 2288999
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral indications for serotonin receptor hypersensitivity in panic disorder.
    Kahn RS; Wetzler S; van Praag HM; Asnis GM; Strauman T
    Psychiatry Res; 1988 Jul; 25(1):101-4. PubMed ID: 3217461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
    Klein E; Zohar J; Geraci MF; Murphy DL; Uhde TW
    Biol Psychiatry; 1991 Nov; 30(10):973-84. PubMed ID: 1756202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.
    Kahn RS; Wetzler S; Asnis GM; Kling MA; Suckow RF; van Praag HM
    Psychiatry Res; 1991 Apr; 37(1):25-34. PubMed ID: 1650487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin receptor sensitivity and aggression.
    Wetzler S; Kahn RS; Asnis GM; Korn M; van Praag HM
    Psychiatry Res; 1991 Jun; 37(3):271-9. PubMed ID: 1891509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
    Silverstone PH; Cowen PJ
    Biol Psychiatry; 1994 Sep; 36(5):309-16. PubMed ID: 7993957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to 5% carbon dioxide in children and adolescents: relationship to panic disorder in parents and anxiety disorders in subjects.
    Pine DS; Klein RG; Roberson-Nay R; Mannuzza S; Moulton JL; Woldehawariat G; Guardino M
    Arch Gen Psychiatry; 2005 Jan; 62(1):73-80. PubMed ID: 15630075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity to challenge with carbon dioxide as a prospective predictor of panic attacks.
    Schmidt NB; Maner JK; Zvolensky MJ
    Psychiatry Res; 2007 May; 151(1-2):173-6. PubMed ID: 17395271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder.
    Bradwejn J; Koszycki D; Meterissian G
    Can J Psychiatry; 1990 Feb; 35(1):83-5. PubMed ID: 2180549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and response to sodium lactate of patients with infrequent panic attacks.
    Cowley DS; Dager SR; Foster SI; Dunner DL
    Am J Psychiatry; 1987 Jun; 144(6):795-8. PubMed ID: 3592002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate-induced panic in primary affective disorder.
    Cowley DS; Dager SR; Dunner DL
    Am J Psychiatry; 1986 May; 143(5):646-8. PubMed ID: 3963256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-HT1A receptor agonist flesinoxan increases aversion in a model of panic-like anxiety in rats.
    Jenck F; Martin JR; Moreau JL
    J Psychopharmacol; 1999; 13(2):166-70. PubMed ID: 10475723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.
    Charney DS; Woods SW; Goodman WK; Heninger GR
    Psychopharmacology (Berl); 1987; 92(1):14-24. PubMed ID: 3110824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDMA ("ecstasy") and panic disorder: induction by a single dose.
    McCann UD; Ricaurte GA
    Biol Psychiatry; 1992 Nov; 32(10):950-3. PubMed ID: 1361366
    [No Abstract]   [Full Text] [Related]  

  • 15. Lactate provocation of panic attacks. I. Clinical and behavioral findings.
    Liebowitz MR; Fyer AJ; Gorman JM; Dillon D; Appleby IL; Levy G; Anderson S; Levitt M; Palij M; Davies SO
    Arch Gen Psychiatry; 1984 Aug; 41(8):764-70. PubMed ID: 6742978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness.
    Breier A; Charney DS; Heninger GR
    Arch Gen Psychiatry; 1986 Nov; 43(11):1029-36. PubMed ID: 3767595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment.
    Norman TR; Gregory MS; Judd FK; Burrows GD; McIntyre IM
    Aust N Z J Psychiatry; 1988 Dec; 22(4):390-5. PubMed ID: 2907288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactate-induced panic attacks: possible involvement of serotonin reuptake stimulation.
    Lingjaerde O
    Acta Psychiatr Scand; 1985 Aug; 72(2):206-8. PubMed ID: 4050513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up study of control subjects with lactate- and isoproterenol-induced panic attacks.
    Balon R; Pohl R; Yeragani VK; Rainey JM; Berchou R
    Am J Psychiatry; 1988 Feb; 145(2):238-41. PubMed ID: 3341469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low doses of clonazepam in the treatment of panic disorder.
    Pols H; Zandbergen J; Lousberg H; de Loof C; Griez E
    Can J Psychiatry; 1991 May; 36(4):302-3. PubMed ID: 1868425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.